Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Hepatitis B Vaccine Comprehensive Patent Search |
Jun 2011 | £4,775 | 100% |
| Hepatitis B Vaccine - Comprehensive patent search | Sep 2011 | £4,775 | 99% |
| Hepatitis B Vaccines Pipeline Assessment and Market Forecasts to 2018 |
Oct 2011 | £2,215 | 99% |
| Competitor Analysis: Hepatitis Vaccines | Jun 2011 | £290 | 99% |
| Hepatitis B Vaccine - Key patent, SPC, and data exclusivity expiry (7 country coverage) Pipeline Selector Core |
Jun 2011 | £310 | 98% |
| Hepatitis B Vaccine - Key patent, SPC, and data exclusivity expiry (44 countries coverage) Pipeline Selector Extended |
Jun 2011 | £705 | 98% |
| Travel Vaccines Market to 2017 Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market |
Apr 2011 | £2,215 | 95% |
| Hepatitis Market to 2017 Strong Hepatitis-C Pipeline, Large Number of Strategic Consolidations and Cost Effective Treatments will Drive the Market |
Jan 2012 | £2,215 | 95% |
| Dynavax Technologies Corporation – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 95% |
| Strategic Analysis of Emerging Vaccines Market in India | Jun 2011 | £3,795 | 95% |
| European Vaccine Markets | Nov 2010 | £1,895 | 95% |
| Opportunities Assessment for Hepatitis B Therapeutics Market in Indonesia | Mar 2009 | £3,795 | 94% |
| Hepatitis B - Pipeline Review H2 2011 |
Sep 2011 | £315 | 94% |
| China Human Vaccine Industry Report 2010-2011 |
May 2011 | £1,390 | 93% |
| Adult and Adolescent Vaccines Market to 2017 Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010 |
Aug 2011 | £2,215 | 93% |
| Stakeholder Opinions: Therapeutic Vaccines A far-off promise of greatness |
Dec 2009 | £2,405 | 93% |
| Epidemiology: Hepatitis B in China | Mar 2011 | £3,605 | 93% |
| Global Hepatitis Strategies | Aug 2007 | £2,525 | 92% |
| Global Vaccines Market 2010-2025 | Mar 2010 | £1,499 | 92% |
| Vaccines 2010 World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry |
Aug 2010 | £2,525 | 92% |
| Vaccines 2011 World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry |
Jul 2011 | £2,655 | 92% |
| Asian Vaccine Markets | Mar 2011 | £2,215 | 91% |
| Hepatitis B - Pipeline Review Q1 2011 |
Mar 2011 | £315 | 91% |
| World Vaccines Market Vaccine Segments Analysis, Vaccine Cases and Future Forecast |
Jan 2010 | £695 | 90% |
| ScientiaVision Product Pinpoint: The New Vaccines | Mar 2009 | £1,895 | 90% |
| Antiviral Therapeutics Technologies, Markets and Companies |
Jan 2012 | £2,265 | 89% |
| Vaccines: US industry forecasts for 2014 & 2019 | Aug 2010 | £2,970 | 89% |
| Infectious Disease Treatments Global Markets |
Apr 2010 | £3,065 | 88% |
| GSK's Cervarix A Future Blockbuster of 2007 |
Mar 2007 | £1,999 | 88% |
| Human Vaccines Global Market Opportunities |
Nov 2009 | £1,895 | 88% |
